Evidence report · Longevity and aging

Peptides

There is no single verdict on 'peptides': the category is too mixed. A few are FDA-approved with real trials (PT-141 for low libido, tesamorelin for visceral fat), while the most-hyped recovery peptides (BPC-157, TB-500) rest almost entirely on animal data. Use only physician-prescribed, quality-sourced, lab-monitored peptides, and get the fundamentals right first. Judge each molecule on its own.

Verdict

Leaning for

Therapeutic peptides such as BPC-157 speed healing and recovery in people.

5 sources: 3 positive, 1 partly, 1 negative

5 sources: 3 positive, 1 partly, 1 negative

5 sources credited9 counted mentions28 episodes · 41 h9 checked quotesChecked against the tape 2026-06-29

Stance update (Aug 2026): A full episode on The Drive sorted peptides into three evidence tiers (discussed on The Drive). It put BPC-157 in the bottom one: no clear mechanism, no human trials, no safety data. It described the gray market as a salvage yard for investigational drugs abandoned in development for lack of efficacy or safety. The peptide is angiogenic, growing blood vessels, which is good or bad depending on what they feed (Andrew Huberman). On the other side, it is called the 'Wolverine peptide', with patients healing tendon and joint injuries on it (Edwin Lee, on The Doctor's Farmacy). Nobody on either side claims a human trial exists, because none does. The dispute is about what to do when the evidence is missing.

Stance update (2025 – 2026): Two things happened at once. Demand exploded into a gray-market 'peptide gold rush' of research-only vials, telehealth and influencer stacks (BPC-157 searches up sharply year-over-year). And regulators tightened: the FDA moved several popular peptides, including BPC-157 and CJC-1295, into 'Category 2,' which effectively bans compounding pharmacies from making them. The net effect is more people buying unproven peptides from less-regulated sources.

Does it work?

Each claim gets one verdict, worked out from every counted mention. One dot is one source: a researcher or a study. Tap a dot to see its receipt.

positive partly neutral negative Each researcher and each study counts once per claim, however often they come up.

  1. Leaning for

    Therapeutic peptides such as BPC-157 speed healing and recovery in people.

    5 sources: 3 positive, 1 partly, 1 negative.

    Researchers say

    3 positive, 1 partly, 1 negative

    Studies show

    No study counted yet.

    43 more not counted · see why
    Show the receipts from 5 sources
    1. Dr. Mark Hyman Video · positive · 2 mentions

      on Huberman Lab, at 2:19:09 · positive · Opinion

      “there's peptides like BPC 157 and TB500 and uh GHK that are regulatory peptides for tissue repair and healing.”

      on The Dr. Hyman Show, at 28:56 · partly · Opinion

      “peptides particularly can be helpful like BP 157”

    2. Dr. Kyle Gillett Video · positive · 2 mentions

      on Huberman Lab, at 30:17 · positive · Opinion

      “The major benefit is when you're going to take it early on because it's going to allow your body to increase blood flow”

      on Huberman Lab, at 2:42:36 · positive · Opinion

      “especially as people age, it's going to make a significant difference.”

    3. Dr. Craig Koniver Video · positive · 2 mentions

      on Huberman Lab, at 21:16 · positive · Opinion

      “bpc is going to benefit it's going to help you know improve the inflammatory status but also help with recovery”

      on Huberman Lab, at 25:12 · positive · Opinion

      “you can inject it in your abdomen or your rear end you're still going to get benefit in your elbow”

    4. Derek, on The Drive, at 3:24:46 Video · partly · Opinion

      “I've seen some pretty remarkable improvements in like minor not complete tears um and certain injuries”

    5. Dr. Peter Attia, on Huberman Lab, at 2:37:29 Video · negative · Opinion

      “we did it for, I don't know, a couple months. I didn't notice a single thing.”

1 more claim on dose, form and timing, each with its verdict and receipts, is in the full report.

How much, which type, and when?

Free with an account ↓
Dose
Form
Timing
Evidence
Verdict
Leaning for · 5 sources: 3 positive, 1 partly, 1 negative

Is it safe for me?

6 risks to check before you start

  1. Contamination is the main danger: gray-market peptides are often tainted with lipopolysaccharide (LPS/endotoxin), which can trigger fever and body-wide inflammation. Most raw material is made overseas with variable, unverified purity (Abud Bakri, on Huberman Lab; Kyle Gillett, on Huberman Lab).
  2. BPC-157 raises VEGF and growth-hormone receptors, a theoretical risk of speeding an existing tumor, which is why continuous or preventive use is discouraged (Andrew Huberman).
  3. Most research peptides have no human randomized trials, no established LD50 (lethal-dose safety data) and no long-term safety record (Abud Bakri, on Huberman Lab). Use rests on animal data and anecdote.
  4. Growth-hormone secretagogues (CJC-1295, ipamorelin, MK-677) carry cancer risk from chronically high GH (Kyle Gillett, on Huberman Lab). Lower GH/IGF-1 after midlife is linked to longer life (Nir Barzilai, on The Doctor's Farmacy).
  5. Legal and quality status is shifting. The FDA moved BPC-157 and CJC-1295 to 'Category 2,' blocking compounding-pharmacy production (Abud Bakri, on Huberman Lab). That pushes buyers toward less-regulated 'research only' sources.
  6. Cost and missing regulation make peptides a 'wild west' where marketing outruns evidence (Peter Attia, on Huberman Lab).

Why do the sources disagree?

Built from every credited researcher and cited study on each claim.

Leaning for

Therapeutic peptides such as BPC-157 speed healing and recovery in people.

Supports it 3 sources
Partly 1 source
Against it 1 source

Precis is not affiliated with or endorsed by YouTube or by any researcher, show or publisher we quote. We take no sponsorship, ad or affiliate money, and every verdict is our own review of what was said. How we stay independent

About This Analysis

This report on Peptides draws on 28 videos (41 hours analyzed) out of 3,700+ hours of recorded interviews with 380 researchers and doctors, plus 48,500+ research studies. Every mention of a claim gets a stance, and the verdict is worked out from all of them, never written by hand.

The full report adds 8 key findings and the dose and protocol. It also has the verdict on every claim, a receipt for each mention, the risks to check, and what combines with it.

Frequently Asked Questions

What does the evidence say about peptides?
There is no single verdict on 'peptides': the category is too mixed. A few are FDA-approved with real trials (PT-141 for low libido, tesamorelin for visceral fat), while the most-hyped recovery peptides (BPC-157, TB-500) rest almost entirely on animal data.
How strong is the evidence on peptides?
The verdict on “Therapeutic peptides such as BPC-157 speed healing and recovery in people” is Leaning for. 5 sources: 3 positive, 1 partly, 1 negative.

Common Questions

Related Reports

Unlock the Full Report

Get dosages, timing and the verdict on every claim with its receipts for Peptides.